Global Infectious Diseases Preliminary Screening Tests Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Infectious Diseases Preliminary Screening Tests market size was valued at US$ 1634 million in 2024 and is forecast to a readjusted size of USD 3135 million by 2031 with a CAGR of 9.9% during review period.

A preliminary screening is a breath or saliva test administered by a law enforcement officer to determine whether an arrest should be made and whether an evidentiary test should be requested. Preliminary screening results may not be used as evidence of impairment in any court proceeding.

As novel viruses continue to emerge and the prevalence of infectious diseases increases, the benefits of rapid testing over laboratory testing increase, government and private sector initiatives aim to grow the healthcare sector, and levels of global health spending Rising, favorable government policies are some of the influencing factors that are likely to accelerate the growth of the infectious disease initial screening tests market.

This report is a detailed and comprehensive analysis for global Infectious Diseases Preliminary Screening Tests market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Infectious Diseases Preliminary Screening Tests market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Infectious Diseases Preliminary Screening Tests market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Infectious Diseases Preliminary Screening Tests market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Infectious Diseases Preliminary Screening Tests market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Infectious Diseases Preliminary Screening Tests

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Infectious Diseases Preliminary Screening Tests market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, BD, Bio-rad Laboratories, Inc, Cepheid, Hologic Inc, Meridian Bioscience, Inc, OraSure Technologies, Inc, Quidel Corporation, F. Hoffmann-La Roche Ltd, BUREAU VERITAS, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Infectious Diseases Preliminary Screening Tests market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Over-the-Counter Rapid Test Product

Professional Rapid Test Product

Market segment by Application

Infectious Diseases

Hepatitis

Influenza

Malaria

HIV

Other

Major players covered

Abbott

BD

Bio-rad Laboratories, Inc

Cepheid

Hologic Inc

Meridian Bioscience, Inc

OraSure Technologies, Inc

Quidel Corporation

F. Hoffmann-La Roche Ltd

BUREAU VERITAS

Eurofins Scientific

Siemens Healthcare Private Limited

Luminex Corporation

PerkinElmer Inc

QIAGEN

Mesa Biotech

Illumina, Inc

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Infectious Diseases Preliminary Screening Tests product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Infectious Diseases Preliminary Screening Tests, with price, sales quantity, revenue, and global market share of Infectious Diseases Preliminary Screening Tests from 2020 to 2025.

Chapter 3, the Infectious Diseases Preliminary Screening Tests competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Infectious Diseases Preliminary Screening Tests breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Infectious Diseases Preliminary Screening Tests market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Infectious Diseases Preliminary Screening Tests.

Chapter 14 and 15, to describe Infectious Diseases Preliminary Screening Tests sales channel, distributors, customers, research findings and conclusion.